Investee Company News

August 16, 2017 Novan Appoints Paula Brown Stafford, Chief Development Officer, to Board of Directors August 11, 2017 Phase 2b Results of Viamet’s Oral VT-1161 for the Treatment of Recurrent Vulvovaginal Candidiasis Presented at IDSOG Annual Meeting August 9, 2017 Cempra and Melinta Announce Merger to Form Leading, Vertically Integrated Commercial-Stage Anti-Infectives Company August 8, 2017 Data on Viamet’s VT-1161 for Treatment of RVVC to be Presented at IDSOG Annual Meeting July 31, 2017 Kymab Announces Clinical Update on its promising new antibody KY1005 for treatment of autoimmune diseases July 27, 2017 Viamet to Present Data on VT-1161 for the Treatment of Onychomycosis at the APMA Annual Meeting July 25, 2017 Novan Announces Corporate Update Conference Call and Webcast July 13, 2017 FDA Grants Fast Track Designation to VT-1598 for Treatment of Valley Fever July 13, 2017 Surgical Specialty Center of Baton Rouge is First Hospital in Southern Louisiana to Enhance Patient Safety by Deploying a Xenex LightStrike Germ-Zapping Robot July 7, 2017 Novan to Present Safety and Efficacy Data for SB204 Program in Adolescents at 13th World Congress of Pediatric Dermatology July 7, 2017 Immunocore and MEPC announce significant laboratory expansion at Milton Park in Oxfordshire, UK July 3, 2017 Immunocore announces third oncology target selected in discovery collaboration with GlaxoSmithKline June 29, 2017 Melinta Signs $90 Million Financing Agreement with Oberland Capital to Fund Baxdela™ Commercial Activities and Expansion into Additional Indications June 21, 2017 Viamet to Present Data on VT-1161 for the Treatment of Onychomycosis at the 4th International Summit on Nail Diseases June 19, 2017 Melinta Therapeutics Announces U.S. FDA Approval of Baxdela™ (Delafloxacin) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) June 16, 2017 Kymab appoints Dr Martin Nicklasson as Non-Executive Chair June 14, 2017 Viamet to Participate in Antifungal Panel Discussion at the 2017 BIO International Convention June 13, 2017 Xenex Announces LightStrike Disinfection Pod™ – Industry’s First Mobile Equipment Disinfection System June 8, 2017 3D4Medical announces exclusive partnership with Sky June 5, 2017 Melinta Therapeutics Demonstrates Potential of Pyrrolocytosine Candidate against Gonorrhea June 5, 2017 Novan Announces Leadership Adjustments and Business Update June 5, 2017 Viamet’s VT-1598 Demonstrates Potent Activity Against Candida auris and Other Life-Threatening Fungal Species June 5, 2017 Poseida Therapeutics Presents High-Fidelity Genome Editing System for Production of Allogeneic “Universal Donor” CAR-T Cells at American Society of Clinical Oncology Annual Meeting June 5, 2017 Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting June 4, 2017 Viamet Presents Phase 2b Results Demonstrating Unprecedented Efficacy of Oral VT-1161 in the Treatment of Recurrent Vulvovaginal Candidiasis June 1, 2017 Melinta Therapeutics Presenting In Vivo and In Vitro Results from Baxdela Studies at ASM Microbe June 1, 2017 Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting May 23, 2017 Teneobio and Poseida Announce License Agreement for the Use of UniDab™ in CAR T-Cell Therapy May 17, 2017 Viamet Data for VT-1161 and VT-1598 to be Presented at The American Society for Microbiology’s ASM Microbe 2017 Conference May 12, 2017 Novan Reports First Quarter 2017 Financial Results